AMRX logo

Amneal Pharmaceuticals (AMRX) Depreciation and amortization

annual D&A:

$236.19M+$6.79M(+2.96%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AMRX annual depreciation & amortization is $236.19 million, with the most recent change of +$6.79 million (+2.96%) on December 31, 2024.
  • During the last 3 years, AMRX annual D&A has risen by +$2.79 million (+1.19%).
  • AMRX annual D&A is now -1.66% below its all-time high of $240.18 million, reached on December 31, 2022.

Performance

AMRX Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

quarterly D&A:

$60.16M-$5.97M(-9.03%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX quarterly depreciation & amortization is $60.16 million, with the most recent change of -$5.97 million (-9.03%) on March 31, 2025.
  • Over the past year, AMRX quarterly D&A has increased by +$4.63 million (+8.34%).
  • AMRX quarterly D&A is now -9.03% below its all-time high of $66.13 million, reached on December 31, 2024.

Performance

AMRX quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM D&A:

$240.82M+$4.63M(+1.96%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX TTM depreciation & amortization is $240.82 million, with the most recent change of +$4.63 million (+1.96%) on March 31, 2025.
  • Over the past year, AMRX TTM D&A has increased by +$14.04 million (+6.19%).
  • AMRX TTM D&A is now at all-time high.

Performance

AMRX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

AMRX Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.0%+8.3%+6.2%
3 y3 years+1.2%+4.0%+2.2%
5 y5 years+14.0%+3.6%+11.3%

AMRX Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.7%+3.0%-9.0%+8.3%at high+6.9%
5 y5-year-1.7%+14.0%-9.0%+8.3%at high+11.3%
alltimeall time-1.7%+615.4%-9.0%+307.8%at high+1532.6%

AMRX Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$60.16M(-9.0%)
$240.82M(+2.0%)
Dec 2024
$236.19M(+3.0%)
$66.13M(+12.2%)
$236.19M(+4.1%)
Sep 2024
-
$58.96M(+6.1%)
$226.99M(+0.8%)
Jun 2024
-
$55.57M(+0.1%)
$225.24M(-0.7%)
Mar 2024
-
$55.53M(-2.5%)
$226.78M(-1.1%)
Dec 2023
$229.40M(-4.5%)
$56.93M(-0.5%)
$229.40M(-1.8%)
Sep 2023
-
$57.21M(+0.2%)
$233.52M(-1.9%)
Jun 2023
-
$57.11M(-1.8%)
$237.93M(-1.1%)
Mar 2023
-
$58.15M(-4.8%)
$240.51M(+0.1%)
Dec 2022
$240.18M(+2.9%)
$61.06M(-0.9%)
$240.18M(-0.1%)
Sep 2022
-
$61.61M(+3.2%)
$240.30M(+0.6%)
Jun 2022
-
$59.70M(+3.3%)
$238.88M(+1.4%)
Mar 2022
-
$57.81M(-5.5%)
$235.67M(+1.0%)
Dec 2021
$233.41M
$61.18M(+1.7%)
$233.41M(+0.6%)
Sep 2021
-
$60.19M(+6.5%)
$232.10M(+0.4%)
DateAnnualQuarterlyTTM
Jun 2021
-
$56.49M(+1.7%)
$231.27M(-0.7%)
Mar 2021
-
$55.55M(-7.2%)
$232.85M(-1.1%)
Dec 2020
$235.39M(+13.6%)
$59.87M(+0.9%)
$235.39M(+2.4%)
Sep 2020
-
$59.36M(+2.2%)
$229.82M(+2.7%)
Jun 2020
-
$58.07M(-0.0%)
$223.82M(+3.4%)
Mar 2020
-
$58.08M(+7.0%)
$216.45M(+4.4%)
Dec 2019
$207.24M(+50.8%)
$54.30M(+1.8%)
$207.24M(+3.4%)
Sep 2019
-
$53.36M(+5.2%)
$200.43M(+5.4%)
Jun 2019
-
$50.71M(+3.8%)
$190.08M(+10.8%)
Mar 2019
-
$48.87M(+2.9%)
$171.52M(+24.8%)
Dec 2018
$137.40M(+199.1%)
$47.49M(+10.4%)
$137.40M(+52.8%)
Sep 2018
-
$43.01M(+33.8%)
$89.91M(+91.7%)
Jun 2018
-
$32.15M(+117.9%)
$46.90M(+217.9%)
Mar 2018
-
$14.75M
$14.75M
Dec 2017
$45.94M(+39.1%)
-
-
Dec 2016
$33.02M
-
-

FAQ

  • What is Amneal Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual D&A year-on-year change?
  • What is Amneal Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly D&A year-on-year change?
  • What is Amneal Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals TTM D&A year-on-year change?

What is Amneal Pharmaceuticals annual depreciation & amortization?

The current annual D&A of AMRX is $236.19M

What is the all time high annual D&A for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual depreciation & amortization is $240.18M

What is Amneal Pharmaceuticals annual D&A year-on-year change?

Over the past year, AMRX annual depreciation & amortization has changed by +$6.79M (+2.96%)

What is Amneal Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of AMRX is $60.16M

What is the all time high quarterly D&A for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly depreciation & amortization is $66.13M

What is Amneal Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, AMRX quarterly depreciation & amortization has changed by +$4.63M (+8.34%)

What is Amneal Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of AMRX is $240.82M

What is the all time high TTM D&A for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high TTM depreciation & amortization is $240.82M

What is Amneal Pharmaceuticals TTM D&A year-on-year change?

Over the past year, AMRX TTM depreciation & amortization has changed by +$14.04M (+6.19%)
On this page